We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZKIN icon
8326
ZK International Group
ZKIN
$65.3M
$9.66K ﹤0.01%
2,300
+2,271
+7,831% +$9.42K
BNR
8327
Burning Rock Biotech
BNR
$94.6M
$9.65K ﹤0.01%
1,430
-2,815
-66% -$13K
KORE
8328
DELISTED
KORE Group Holdings
KORE
$9.63K ﹤0.01%
2,992
-3,198
-52% -$6.01K
GGRW icon
8329
Gabelli Growth Innovators ETF
GGRW
$7.68M
$9.61K ﹤0.01%
321
-639
-67% -$19K
DMAC icon
8330
DiaMedica Therapeutics
DMAC
$352M
$9.61K ﹤0.01%
1,769
-10,970
-86% -$51.7K
ELVA
8331
Electrovaya
ELVA
$455M
$9.59K ﹤0.01%
3,865
+2,140
+124% +$5.01K
MDPL icon
8332
Monarch Dividend Plus Index ETF
MDPL
$61M
$9.54K ﹤0.01%
377
+227
+151% +$6.04K
SHEH
8333
Shell PLC ADRhedged
SHEH
$6.48M
$9.54K ﹤0.01%
+200
New +$9.8K
RAYS
8334
DELISTED
Global X Solar ETF
RAYS
$9.53K ﹤0.01%
1,066
+966
+966% +$9.92K
SATX
8335
DELISTED
SatixFy Communications
SATX
$9.53K ﹤0.01%
6,226
+76
+1% +$67
BJDX icon
8336
Bluejay Diagnostics
BJDX
$1.03M
$9.47K ﹤0.01%
486
+179
+58% +$3.34K
TMAT icon
8337
Main Thematic Innovation ETF
TMAT
$253M
$9.46K ﹤0.01%
+454
New +$9.04K
AXG
8338
Solowin Holdings
AXG
$566M
$9.46K ﹤0.01%
+5,733
New +$14.1K
NTSI icon
8339
WisdomTree International Efficient Core Fund
NTSI
$502M
$9.45K ﹤0.01%
+269
New +$9.88K
UCL
8340
uCloudlink Group
UCL
$32.8M
$9.45K ﹤0.01%
+4,500
New +$6.12K
XAGE
8341
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$9.42K ﹤0.01%
1,126
+717
+175% +$6.81K
IDR icon
8342
Idaho Strategic Resources
IDR
$482M
$9.39K ﹤0.01%
922
+61
+7% +$822
RSVRW
8343
DELISTED
Reservoir Media Inc Warrant
RSVRW
$9.38K ﹤0.01%
6,469
-2,025
-24% -$2.62K
TRIB
8344
Trinity Biotech
TRIB
$7.43M
$9.35K ﹤0.01%
+354
New +$14.2K
HYZN
8345
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$9.28K ﹤0.01%
8,800
+7,317
+493% +$13K
SDP icon
8346
ProShares UltraShort Utilities
SDP
$4.17M
$9.27K ﹤0.01%
277
+87
+46% +$2.72K
LRE
8347
Lead Real Estate
LRE
$17.5M
$9.17K ﹤0.01%
4,958
+3,032
+157% +$5.87K
JFU
8348
9F Inc
JFU
$28.8M
$9.17K ﹤0.01%
6,071
+5,363
+757% +$8.99K
FTXL icon
8349
First Trust Nasdaq Semiconductor ETF
FTXL
$1.45B
$9.16K ﹤0.01%
105
-1,262
-92% -$114K
IBHK
8350
iShares iBonds 2031 Term High Yield and Income ETF
IBHK
$71.3M
$9.16K ﹤0.01%
+362
New +$9.3K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.